Synlogic Inc

General ticker "SYBX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $17.5M

Synlogic Inc does not follow the US Stock Market performance with the rate: -38.8%.

Estimated limits based on current volatility of 2.8%: low 1.35$, high 1.43$

Factors to consider:

  • Current price 31.5% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.02$, 6.27$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.49$, 6.74$]

Financial Metrics affecting the SYBX estimates:

  • Negative: Non-GAAP EPS, $ of -10.88 <= 0.10
  • Negative: Operating profit margin, % of -94.24 <= 1.03
  • Negative: Operating cash flow per share per price, % of -72.40 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Positive: Interest expense per share, $ of 0 <= 0.14

Similar symbols

Short-term SYBX quotes

Long-term SYBX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.75MM $1.18MM $3.37MM
Operating Expenses $62.52MM $68.60MM $58.53MM
Operating Income $-60.77MM $-67.42MM $-55.16MM
Non-Operating Income $0.20MM $1.27MM $-2.11MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $47.13MM $52.04MM $43.97MM
Income(Loss) $-60.56MM $-66.15MM $-57.27MM
Taxes $0.00MM $0.00MM $0.01MM
Profit(Loss) $-60.56MM $-66.15MM $-57.28MM
Stockholders Equity $147.27MM $82.61MM $42.66MM
Assets $174.74MM $110.86MM $75.55MM
Operating Cash Flow $-52.20MM $-56.89MM $-51.61MM
Capital expenditure $0.68MM $0.73MM $0.21MM
Investing Cash Flow $-53.25MM $58.35MM $38.77MM
Financing Cash Flow $89.38MM $-2.04MM $20.94MM
Earnings Per Share* $-15.76 $-13.57 $-8.81

* EPS are Split Adjusted, recent splits may be reflected with a delay.